Presentation Information
[O-04-5]the transition to the subcutaneous injection of the FcRn inhibitor for generalized myasthenia gravis
Masaaki Yoshikawa1, Yuta Goto1, Takeru Kawanami1, Koya Tanaka2, Keisuke Tsumura1, Yuki Hoshino1, Toshihiro Ide1, Chika Shichijo1, Kohei Suzuyama1, Megumi Iwasaki3, Makoto Eriguchi2, Motohiro Yukitake4, Hiroshi Takashima2, Haruki Koike1 (1.Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan, 2.Department of Neurology, Saga-Ken Medical Centre Koseikan, Japan, 3.Department of Neurology, Karatsu Red Cross Hospital, Japan, 4.Department of Neurology, Kouhoukai Takagi Hospital, Japan)